Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to -$3.9 million.

  • Lemaitre Vascular's Change in Receivables fell 51358.81% to -$3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $386000.0, marking a year-over-year decrease of 9545.51%. This contributed to the annual value of $6.4 million for FY2024, which is 10472.09% up from last year.
  • As of Q3 2025, Lemaitre Vascular's Change in Receivables stood at -$3.9 million, which was down 51358.81% from $680000.0 recorded in Q2 2025.
  • Over the past 5 years, Lemaitre Vascular's Change in Receivables peaked at $5.8 million during Q1 2024, and registered a low of -$3.9 million during Q3 2025.
  • Its 5-year average for Change in Receivables is $805631.6, with a median of $743000.0 in 2024.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 35699.75% in 2022, then tumbled by 51358.81% in 2025.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Change in Receivables stood at $393000.0 in 2021, then skyrocketed by 357.0% to $1.8 million in 2022, then tumbled by 41.09% to $1.1 million in 2023, then tumbled by 196.12% to -$1.0 million in 2024, then tumbled by 283.09% to -$3.9 million in 2025.
  • Its last three reported values are -$3.9 million in Q3 2025, $680000.0 for Q2 2025, and $4.6 million during Q1 2025.